论文部分内容阅读
肝细胞肝癌传统的根治方法是手术切除,应用范围窄,肝移植术为肝癌患者提供了一个理想的根治性治疗方法,但肿瘤的复发和转移往往造成手术失败,因此对于手术而言,把握合理的手术指征是治疗成功的关键,新的化疗药物的发展,以及分子靶向药物的出现和在临床的广泛应用,进一步提升了围手术期全身化疗的作用,结合免疫抑制剂的合理调整,为肝癌根治治疗提供了希望。
The traditional radical treatment of hepatocellular carcinoma is surgically removed and has a narrow range of applications. Liver transplantation provides an ideal radical treatment for patients with liver cancer. However, the recurrence and metastasis of the tumor often result in the failure of surgery. Therefore, it is reasonable for the operation Of the surgical indications is the key to the success of the treatment, the development of new chemotherapeutic drugs, and the emergence of molecular targeted drugs and its widespread use in the clinic, to further enhance the role of perioperative systemic chemotherapy, combined with the reasonable adjustment of immunosuppressive agents, It provides hope for the radical treatment of liver cancer.